Charged particle radiation therapy for uveal melanoma

A systematic review and meta-analysis

Zhen Wang, Mohammed Nabhan, Steven E. Schild, Scott L. Stafford, Ivy A Petersen, Robert L. Foote, Mohammad H Murad

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Charged particle therapy (CPT) delivered with either protons, helium ions, or carbon ions, has been used to treat uveal melanoma. The present analysis was performed to systematically evaluate the efficacy and adverse effects of CPT for uveal melanoma. We searched EMBASE, MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and SciVerse Scopus and cross-referenced recent systematic reviews through January 2012. Two independent reviewers identified clinical trials and observational studies of CPT (protons, helium ions, and carbon ions). These reviewers extracted data and assessed study quality. Twenty-seven studies enrolling 8809 uveal melanoma patients met inclusion criteria. The rate of local recurrence was significantly less with CPT than with brachytherapy (odds ratio [OR] = 0.22, 95% confidence interval [CI], 0.21-0.23). There were no significant differences in mortality or enucleation rates. Results were robust in multiple sensitivity analyses. CPT was also associated with lower retinopathy and cataract formation rates. Data suggest better outcomes may be possible with charged particle therapy with respect to local recurrence, retinopathy, and cataract formation rates. The overall quality of the evidence is low, and higher quality comparative effectiveness studies are needed to provide better evidence.

Original languageEnglish (US)
Pages (from-to)18-26
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume86
Issue number1
DOIs
StatePublished - May 1 2013

Fingerprint

Meta-Analysis
radiation therapy
therapy
charged particles
Radiotherapy
Ions
Helium
cataracts
helium ions
Cataract
Carbon
Proton Therapy
Therapeutics
Recurrence
Brachytherapy
protons
MEDLINE
mortality
carbon
registers

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Charged particle radiation therapy for uveal melanoma : A systematic review and meta-analysis. / Wang, Zhen; Nabhan, Mohammed; Schild, Steven E.; Stafford, Scott L.; Petersen, Ivy A; Foote, Robert L.; Murad, Mohammad H.

In: International Journal of Radiation Oncology Biology Physics, Vol. 86, No. 1, 01.05.2013, p. 18-26.

Research output: Contribution to journalArticle

@article{86407a98a33e4df3898a49c2485cd58a,
title = "Charged particle radiation therapy for uveal melanoma: A systematic review and meta-analysis",
abstract = "Charged particle therapy (CPT) delivered with either protons, helium ions, or carbon ions, has been used to treat uveal melanoma. The present analysis was performed to systematically evaluate the efficacy and adverse effects of CPT for uveal melanoma. We searched EMBASE, MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and SciVerse Scopus and cross-referenced recent systematic reviews through January 2012. Two independent reviewers identified clinical trials and observational studies of CPT (protons, helium ions, and carbon ions). These reviewers extracted data and assessed study quality. Twenty-seven studies enrolling 8809 uveal melanoma patients met inclusion criteria. The rate of local recurrence was significantly less with CPT than with brachytherapy (odds ratio [OR] = 0.22, 95{\%} confidence interval [CI], 0.21-0.23). There were no significant differences in mortality or enucleation rates. Results were robust in multiple sensitivity analyses. CPT was also associated with lower retinopathy and cataract formation rates. Data suggest better outcomes may be possible with charged particle therapy with respect to local recurrence, retinopathy, and cataract formation rates. The overall quality of the evidence is low, and higher quality comparative effectiveness studies are needed to provide better evidence.",
author = "Zhen Wang and Mohammed Nabhan and Schild, {Steven E.} and Stafford, {Scott L.} and Petersen, {Ivy A} and Foote, {Robert L.} and Murad, {Mohammad H}",
year = "2013",
month = "5",
day = "1",
doi = "10.1016/j.ijrobp.2012.08.026",
language = "English (US)",
volume = "86",
pages = "18--26",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Charged particle radiation therapy for uveal melanoma

T2 - A systematic review and meta-analysis

AU - Wang, Zhen

AU - Nabhan, Mohammed

AU - Schild, Steven E.

AU - Stafford, Scott L.

AU - Petersen, Ivy A

AU - Foote, Robert L.

AU - Murad, Mohammad H

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Charged particle therapy (CPT) delivered with either protons, helium ions, or carbon ions, has been used to treat uveal melanoma. The present analysis was performed to systematically evaluate the efficacy and adverse effects of CPT for uveal melanoma. We searched EMBASE, MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and SciVerse Scopus and cross-referenced recent systematic reviews through January 2012. Two independent reviewers identified clinical trials and observational studies of CPT (protons, helium ions, and carbon ions). These reviewers extracted data and assessed study quality. Twenty-seven studies enrolling 8809 uveal melanoma patients met inclusion criteria. The rate of local recurrence was significantly less with CPT than with brachytherapy (odds ratio [OR] = 0.22, 95% confidence interval [CI], 0.21-0.23). There were no significant differences in mortality or enucleation rates. Results were robust in multiple sensitivity analyses. CPT was also associated with lower retinopathy and cataract formation rates. Data suggest better outcomes may be possible with charged particle therapy with respect to local recurrence, retinopathy, and cataract formation rates. The overall quality of the evidence is low, and higher quality comparative effectiveness studies are needed to provide better evidence.

AB - Charged particle therapy (CPT) delivered with either protons, helium ions, or carbon ions, has been used to treat uveal melanoma. The present analysis was performed to systematically evaluate the efficacy and adverse effects of CPT for uveal melanoma. We searched EMBASE, MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and SciVerse Scopus and cross-referenced recent systematic reviews through January 2012. Two independent reviewers identified clinical trials and observational studies of CPT (protons, helium ions, and carbon ions). These reviewers extracted data and assessed study quality. Twenty-seven studies enrolling 8809 uveal melanoma patients met inclusion criteria. The rate of local recurrence was significantly less with CPT than with brachytherapy (odds ratio [OR] = 0.22, 95% confidence interval [CI], 0.21-0.23). There were no significant differences in mortality or enucleation rates. Results were robust in multiple sensitivity analyses. CPT was also associated with lower retinopathy and cataract formation rates. Data suggest better outcomes may be possible with charged particle therapy with respect to local recurrence, retinopathy, and cataract formation rates. The overall quality of the evidence is low, and higher quality comparative effectiveness studies are needed to provide better evidence.

UR - http://www.scopus.com/inward/record.url?scp=84876141172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876141172&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2012.08.026

DO - 10.1016/j.ijrobp.2012.08.026

M3 - Article

VL - 86

SP - 18

EP - 26

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -